Black Diamond Therapeutics (BDTX) Interest & Investment Income: 2018-2021

Historic Interest & Investment Income for Black Diamond Therapeutics (BDTX) over the last 4 years, with Dec 2021 value amounting to $3.5 million.

  • Black Diamond Therapeutics' Interest & Investment Income fell 53.11% to $588,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $3.8 million, marking a year-over-year increase of 4.72%. This contributed to the annual value of $3.5 million for FY2021, which is 14.28% down from last year.
  • As of FY2021, Black Diamond Therapeutics' Interest & Investment Income stood at $3.5 million, which was down 14.28% from $4.0 million recorded in FY2020.
  • In the past 5 years, Black Diamond Therapeutics' Interest & Investment Income registered a high of $4.0 million during FY2020, and its lowest value of $4,000 during FY2018.
  • Moreover, its 3-year median value for Interest & Investment Income was $3.5 million (2021), whereas its average is $2.7 million.
  • As far as peak fluctuations go, Black Diamond Therapeutics' Interest & Investment Income soared by 11,425.00% in 2019, and later dropped by 14.28% in 2021.
  • Yearly analysis of 4 years shows Black Diamond Therapeutics' Interest & Investment Income stood at $4,000 in 2018, then skyrocketed by 11,425.00% to $461,000 in 2019, then skyrocketed by 776.57% to $4.0 million in 2020, then decreased by 14.28% to $3.5 million in 2021.